Agios Pharma (AGIO) Tops Q3 EPS by $1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Join SI Premium – FREE
Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of $16.22, $1.00 better than the analyst estimate of $15.22. Revenue for the quarter came in at $9 million versus the consensus estimate of $9.47 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SK Hynix could join the Nasdaq 100 if it expands its ADR float: Goldman
- AppTech Payments outlines strategy shift in shareholder letter
- Norfolk Southern (NSC) Tops Q3 EPS by 14c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
